DK1172098T3 - Øjendråbesammensætning indeholdende ketotifen - Google Patents

Øjendråbesammensætning indeholdende ketotifen

Info

Publication number
DK1172098T3
DK1172098T3 DK01124282.3T DK01124282T DK1172098T3 DK 1172098 T3 DK1172098 T3 DK 1172098T3 DK 01124282 T DK01124282 T DK 01124282T DK 1172098 T3 DK1172098 T3 DK 1172098T3
Authority
DK
Denmark
Prior art keywords
composition containing
eye drop
drop composition
containing ketotifen
ketotifen
Prior art date
Application number
DK01124282.3T
Other languages
English (en)
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235893&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1172098(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1172098T3 publication Critical patent/DK1172098T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01124282.3T 1998-01-15 1999-01-13 Øjendråbesammensætning indeholdende ketotifen DK1172098T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810016A EP0938896A1 (en) 1998-01-15 1998-01-15 Autoclavable pharmaceutical compositions containing a chelating agent
EP99906123A EP1047406B1 (en) 1998-01-15 1999-01-13 Autoclavable pharmaceutical compositions containing a chelating agent

Publications (1)

Publication Number Publication Date
DK1172098T3 true DK1172098T3 (da) 2011-03-14

Family

ID=8235893

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99906123T DK1047406T3 (da) 1998-01-15 1999-01-13 Autoklaverbar farmaceutisk sammensætning indeholdende en chelatdanner
DK01124282.3T DK1172098T3 (da) 1998-01-15 1999-01-13 Øjendråbesammensætning indeholdende ketotifen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99906123T DK1047406T3 (da) 1998-01-15 1999-01-13 Autoklaverbar farmaceutisk sammensætning indeholdende en chelatdanner

Country Status (12)

Country Link
US (2) US6468548B1 (da)
EP (4) EP0938896A1 (da)
JP (2) JP5442919B2 (da)
AT (2) ATE491434T1 (da)
AU (1) AU742920B2 (da)
CA (1) CA2315767C (da)
CY (1) CY1111126T1 (da)
DE (2) DE69943051D1 (da)
DK (2) DK1047406T3 (da)
ES (2) ES2356229T3 (da)
PT (2) PT1172098E (da)
WO (1) WO1999036055A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775832B2 (en) * 1998-01-15 2004-08-19 Novartis Ag Ophthalmic composition
AU757896B2 (en) * 1998-09-02 2003-03-13 Allergan, Inc. Preserved cyclodextrin-containing compositions
US6777429B1 (en) 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
US20030077302A1 (en) * 2000-01-20 2003-04-24 Gudrun Claus-Herz Diclofenamide suspension gel
MXPA03004546A (es) * 2000-11-22 2003-09-10 Rxkinetix Inc Tratamiento de mucositis.
US20040214797A1 (en) * 2001-05-07 2004-10-28 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
EP1480677B8 (en) * 2001-11-21 2012-05-23 Carl Zeiss Meditec SAS Composition for stabilizing hyaluronic acid
DE10262084B4 (de) * 2002-05-17 2009-12-24 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
DK1585548T3 (da) * 2002-12-09 2018-09-03 Abraxis Bioscience Llc Sammensætninger og fremgangsmåder til afgivelse af farmakologiske midler
EP1454636A1 (en) * 2003-03-04 2004-09-08 Dompé S.P.A. Sterilization of glucocorticoid drug particles for pulmonary delivery
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
EP1845983B1 (en) * 2004-10-25 2010-04-07 Bausch & Lomb Incorporated Ophthalmic compositions and methods of using the same
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
US7178703B2 (en) 2004-11-23 2007-02-20 Allergan, Inc. Autoclaveable small-volume dropper bottle
US20060186005A1 (en) * 2005-02-24 2006-08-24 Sina Ebnesajjad Terminally sterilizing pharmaceutical package
US20060243696A1 (en) * 2005-04-27 2006-11-02 Spada Lon T Tip design for reducing capillary leakage and water loss for plastic container closures
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
BRPI0709549A2 (pt) * 2006-03-17 2011-07-19 Johnson & Johnson Vision Care métodos para estabilizar composições instáveis oxidativamente
US20070238789A1 (en) * 2006-03-31 2007-10-11 Chin-Ming Chang Prednisolone acetate compositions
ES2624960T3 (es) * 2006-09-29 2017-07-18 Johnson & Johnson Vision Care, Inc. Método de fabricación de dispositivos oftálmicos usados en el tratamiento de alergias oculares
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
JP5460996B2 (ja) * 2007-10-19 2014-04-02 大正製薬株式会社 眼科用剤
MD3975C2 (ro) * 2007-11-07 2010-06-30 Технический университет Молдовы Sistem de orientare a instalaţiei solare paraboloidale (variante)
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
JP6462201B2 (ja) * 2012-06-14 2019-01-30 ロート製薬株式会社 水性眼科組成物
ITMI20122002A1 (it) * 2012-11-26 2014-05-27 Farmacologico Milanese Srl Lab Preparazioni farmaceutiche liquide stabilizzate
US10174006B2 (en) * 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
GEP20196982B (en) * 2014-01-10 2019-06-25 Pharmaceutical Co Ltd Santen Pharmaceutical composition containing pyridylamino acetic acid compound
ES2747808T3 (es) * 2014-05-07 2020-03-11 Croma Pharma Ges M B H Solución oftálmica acuosa y método para tratar el síndrome del ojo seco
GB201419540D0 (en) * 2014-11-03 2014-12-17 Nanomerics Ltd Delivery of drugs
US9694003B2 (en) 2015-10-15 2017-07-04 Bridge Pharma, Inc. Formulations and methods for treating high intraocular pressure
CN106109407A (zh) * 2016-08-25 2016-11-16 安徽环球药业股份有限公司 盐酸安妥沙星氯化钠注射液的配制方法
PL3548091T3 (pl) 2016-11-29 2022-03-28 Oculis SA Otrzymywanie stałych kompleksów cyklodekstryny do dostarczenia czynnego składnika farmaceutycznego do oczu
CN109833294B (zh) * 2019-04-19 2020-06-09 江苏远恒药业有限公司 一种盐酸洛美沙星滴眼液及其制备工艺
CA3178254A1 (en) * 2020-05-18 2021-11-25 Jack Martin LIPMAN Low-dose carbachol compositions and methods for treatment of night vision disturbance

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
JPS5428810A (en) * 1977-08-01 1979-03-03 American Home Prod Pharmaceutical composition for eye disease containing 1*33dioxoo1hhbenzo *d * e* isoquinolinee2*3h**acetic acid
JPS62277323A (ja) * 1986-02-19 1987-12-02 Sankyo Co Ltd フマル酸ケトチフエン含有点眼液の製法
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US5165918A (en) * 1988-06-28 1992-11-24 Ciba-Geigy Corporation Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same
CA2044878C (en) * 1990-08-07 2000-12-26 Tacey X. Viegas Thermally reversible and irreversible gels
EP0492902A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyridine derivatives for use in the treatment of glaucoma
EP0492904A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted benzene derivatives for use in the treatment of glaucoma
US5182102A (en) * 1991-07-12 1993-01-26 Alcon Laboratories, Inc. Anti-glaucoma compositions
AU666957B2 (en) * 1992-08-28 1996-02-29 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
JP3597239B2 (ja) * 1994-03-31 2004-12-02 ライオン株式会社 安定な点眼剤
JPH07324034A (ja) * 1994-05-30 1995-12-12 Toa Yakuhin Kk フマル酸ケトチフェン含有の点眼剤
JP3055753B2 (ja) * 1994-07-05 2000-06-26 昭和薬品化工株式会社 フマル酸ケトチフェン含有点眼液
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
JPH09301873A (ja) * 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd サルファ剤の可溶化方法及びサルファ剤を可溶化させた水性薬剤
ES2161473T3 (es) * 1996-09-20 2001-12-01 Bausch & Lomb Metodo y composicion para rehumedecer lentes de contacto y aliviar la sequedad ocular.
WO1999051230A1 (en) * 1998-04-02 1999-10-14 Novartis Ag Method for stabilizing pharmaceutical compositions by special use of an antioxidant
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent

Also Published As

Publication number Publication date
DE69907137D1 (de) 2003-05-28
JP2011168601A (ja) 2011-09-01
CY1111126T1 (el) 2015-06-11
ES2198127T3 (es) 2004-01-16
JP5587237B2 (ja) 2014-09-10
AU2616999A (en) 1999-08-02
ES2356229T3 (es) 2011-04-06
US20020165254A1 (en) 2002-11-07
ATE238036T1 (de) 2003-05-15
EP1172098B1 (en) 2010-12-15
EP1047406A1 (en) 2000-11-02
US6468548B1 (en) 2002-10-22
EP2281554A1 (en) 2011-02-09
DE69907137T2 (de) 2003-11-27
EP1047406B1 (en) 2003-04-23
CA2315767C (en) 2008-10-28
EP0938896A1 (en) 1999-09-01
DE69943051D1 (de) 2011-01-27
ATE491434T1 (de) 2011-01-15
PT1172098E (pt) 2011-02-01
PT1047406E (pt) 2003-08-29
DK1047406T3 (da) 2003-07-21
US6776982B2 (en) 2004-08-17
EP1172098A1 (en) 2002-01-16
AU742920B2 (en) 2002-01-17
JP5442919B2 (ja) 2014-03-19
JP2002509101A (ja) 2002-03-26
CA2315767A1 (en) 1999-07-22
WO1999036055A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
DK1172098T3 (da) Øjendråbesammensætning indeholdende ketotifen
FI20050238A (fi) Markfortiini- ja paraherkvamidiyhdisteet
DE69917651D1 (de) Hornhautlinse
NO960567L (no) Termostabile xylanaser
NO995946D0 (no) Formede oftalmiske linser
DK1051206T3 (da) En multi-formet medicinsk anordning af kollagenbaseret biomateriale
DE69931419D1 (de) Ophthalmologisches Gerät
HK1048662A1 (en) Hybrid refractive birefringent multifocal ophthalmic lenses
PE14199A1 (es) Agonistas de 5-ht1f
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
DE60038755D1 (de) Material für Okularlinse
DE69927069D1 (de) Ophthalmisches Gerät
ATE271390T1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
EE200200040A (et) Ketotifeeni sisaldav oftalmiline ravimkoostis
DE69908232D1 (de) Laserbehandlungsvorrichtung
ATA37998A (de) Sichtscheibe für eine skibrille
DE60200302D1 (de) Laseraugenbehandlungseinrichtung
ATE517110T1 (de) 4-ketolactames et ketolactones substitues en 3 et biphenyl-substitues en 3 et leur utilisation en tant que pesticides
FR2702955B1 (fr) Instrument pour chirurgie oculaire.
NO20002408D0 (no) 5-HT1F antagonister
DE60211547D1 (de) Für flaschenverpackungsstrassen bestimmte maschine zur automatischen abgabe von schutz-trenn-teilern für flaschengruppen
ATE449546T1 (de) Aufnahmevorrichtung für brille
DE1042999T1 (de) Halter für eine Intraocularlinse
ATA18622001A (de) Vorrichtung zum abblocken von optischen gläsern
FR2704422B3 (fr) Implant oculaire.